https://www.twobearcapital.com/2026-05-06T01:10:53.759Zweekly1.0https://www.twobearcapital.com/contact/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/focus/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/jobs/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/abilita-therapeutics/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/arch-systems/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/binarly/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/ciq/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/conceal/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/dymium/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/elisity/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/fyr-bio/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/graphiant/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/gravwell/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/inimmune/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/leapfrog-bio/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/montara-therapeutics/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/novoron/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/pulsedata/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/qusecure/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/rainfall-health/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/revenium/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/sanavia-oncology/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/selector/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/talus-bio/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/portfolio/tiledb/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/privacy-policy/2026-05-06T01:10:53.759Zmonthly0.3https://www.twobearcapital.com/story/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/amalia-colangelo/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/ashley-archibeque/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/avery-sonnenberg/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/bria-iuliano/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/bridget-martell-ma-md/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/cris-neckar/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/ellen-lubman/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/eric-fulton/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/erika-bolden/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/j-seth-strattan/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/james-allison/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/jeff-miller/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/jenna-aronson/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/jennifer-howrigan/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/jim-caggiano/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/joe-pinto/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/john-delaney/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/john-sullivan/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/kevin-day/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/kristen-getchell/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/lavinia-platerink/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/linda-jahn/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/liz-marchi/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/mark-adams/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/meagan-hennig/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/mike-goguen/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/neil-white/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/nikki-johns/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/padmanee-sharma/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/rachel-tsunemoto-hislop/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/tim-veil/2026-05-06T01:10:53.759Zmonthly0.7https://www.twobearcapital.com/team/zander-mykytiuk/2026-05-06T01:10:53.759Zmonthly0.7